New delivery system helps delay peptide breakdown in diabetes

01/30/2013 | Wired.co.uk (U.K.)

Researchers at Duke University have developed a jelly-based delivery method to help delay the process of peptide drug breakdown in diabetes patients. The method uses an injectable fusion protein that fuses peptide drug copies with heat-sensitive polymers. The protein, which is less painful and easier to inject than microsphere-release technology, turns into jelly inside the body and is slowly broken down by enzymes to release the peptides.

View Full Article in:

Wired.co.uk (U.K.)

Published in Briefs:

SmartBrief Job Listings for Education

Job Title Company Location
Senior Researcher (8194)
American Institute for Researcher
Washington, DC
Technical Assistance Associate (8330)
American Institute for Researcher
Chicago, IL
Technical Assistance Consultant (8336)
Am
Chicago, IL
Director of Professional Services
Engaging Schools, Inc.
Cambridge, MA
Principal at Timberland Charter Academy
Timberland Charter Academy
Muskegon, MI